0001896212
false
0001896212
2023-08-16
2023-08-16
0001896212
MURF:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember
2023-08-16
2023-08-16
0001896212
MURF:ClassCommonStockParValue0.0001PerShareMember
2023-08-16
2023-08-16
0001896212
MURF:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member
2023-08-16
2023-08-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 16, 2023
Murphy
Canyon Acquisition Corp.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-41245 |
|
87-3272543 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
4995
Murphy Canyon Road, Suite 300
San
Diego, California |
|
92123 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: 760-471-8536
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of
the following provisions:
☒ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
|
|
|
|
|
Units,
each consisting of one share of Class A Common Stock and one Redeemable Warrant |
|
MURFU |
|
The
Nasdaq Stock Market LLC |
|
|
|
|
|
Class
A Common Stock, par value $0.0001 per share |
|
MURF |
|
The
Nasdaq Stock Market LLC |
|
|
|
|
|
Redeemable
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 |
|
MURFW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
8.01. Other Events.
On
August 16, 2023, Murphy Canyon Acquisition Corp. (the “Company”) issued a press release announcing that it has scheduled
a special meeting of its stockholders for September 7, 2023 at 10:00 a.m., Eastern time, to approve the previously announced business
combination (the “Business Combination”) with Conduit Pharmaceuticals Limited (“Conduit”), that the Company’s
proxy statement/registration statement on Form S-4 filed with the Securities and Exchange Commission (“SEC”) on May 12, 2023,
as amended (the “Registration Statement”), was declared effective by the SEC on August 11, 2023 and that the Company has
commenced mailing the proxy statement and prospectus to its stockholders of record as of the close of business on August 2, 2023.
A
copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Important
Information for Investors and Stockholders and Where to Find It
In
connection with the transactions described herein, Murphy Canyon filed the Registration Statement that includes a proxy statement with
respect to the stockholder meeting of Murphy Canyon and a prospectus with respect to securities of the combined company. The proxy statement/prospectus
was sent to all Murphy Canyon stockholders. Murphy Canyon will also file other documents regarding the proposed Business Combination
with the SEC. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITIES HOLDERS OF MURPHY CANYON ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS
AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED BUSINESS COMBINATION AS THEY
BECOME AVAILABLE SINCE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION AND THE PARTIES TO THE PROPOSED
BUSINESS COMBINATION.
Investors
and securities holders are able to obtain free copies of the Registration Statement, proxy statement/prospectus and all other relevant
documents filed or that will be filed with the SEC by Murphy Canyon through the website maintained by the SEC at https://sec.gov/. In
addition, the documents filed by Murphy Canyon may be obtained free of charge from Murphy Canyon’s website at https://murphycanyonac.com
or by written request to info@murphycanyonac.com. Additional information about the Business Combination, including a copy
of the agreement and plan of merger (the “Business Combination Agreement”) by and among
the Company, Conduit and Conduit Merger Sub, Inc., a Cayman Islands exempted company and a wholly owned subsidiary of the Company and
investor presentations, were provided in Current Reports on Form 8-K filed by Murphy Canyon with the SEC which can be accessed at www.sec.gov
as well as online at https://murphycanyonac.com.
Participants
in Solicitation
Murphy
Canyon, Conduit, and their respective directors and executive officers, under SEC rules, may be deemed to be participants in the solicitation
of proxies of Murphy Canyon’s stockholders in connection with the proposed business combination. Investors and security holders
may obtain more detailed information regarding the names and interests in the proposed business combination of Murphy Canyon’s
directors and officers in Murphy Canyon’s filings with the SEC, including Murphy Canyon’s initial public offering prospectus,
which was filed with the SEC on February 2, 2022, Murphy Canyon’s subsequent quarterly reports on Form 10-Q, annual reports on
Form 10-K and the Registration Statement. To the extent that holdings of Murphy Canyon’s securities by Murphy Canyon’s insiders
have changed from the amounts reported therein, any such changes have been or will be reflected on Statements of Change in Ownership
on Form 4 filed with the SEC. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation
of proxies to Murphy Canyon’s stockholders in connection with the business combination are included in the proxy statement/prospectus
relating to the proposed business combination. You may obtain free copies of these documents as described in the preceding paragraph.
No
Offer or Solicitation
This
communication shall not constitute a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities
or in respect of the proposed business combination. This communication shall also not constitute an offer to sell or a solicitation of
an offer to buy any securities of Murphy Canyon or Conduit, nor shall there be any sale of securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10
of the Securities Act of 1933, as amended.
Forward-Looking
Statements
This
Form 8-K, exhibit hereto and information incorporated by reference herein, contain certain forward-looking statements within the meaning
of the federal securities laws with respect to the proposed transaction between Murphy Canyon and Conduit. All statements other than
statements of historical facts contained in this Form 8-K, exhibit hereto and information incorporated by reference herein, including
statements regarding Murphy Canyon or Conduit’s future results of operations and financial position, the amount of cash expected
to be available to Conduit after the closing and giving effect to any redemptions by Murphy Canyon’s stockholders, Conduit’s
business strategy, prospective product candidates, product approvals, research and development costs, timing and likelihood of success,
plans and objectives of management for future operations, future results of current and anticipated product candidates, and expected
use of proceeds, are forward-looking statements. These forward-looking statements generally are identified by the words “believe,”
“project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,”
“future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,”
“will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, the following risks relating
to the proposed transaction: the occurrence of any event, change or other circumstances that could give rise to the termination of the
Business Combination Agreement; the risk that the transaction may not be completed in a timely manner or at all, which may adversely
affect the price of Murphy Canyon’s securities; the occurrence of any event, change or other circumstances that could give rise
to the termination of the Business Combination Agreement; the inability to complete the Business Combination, including due to failure
to obtain approval of the stockholders of Murphy Canyon or other conditions to closing in the Business Combination Agreement; the inability
to obtain or maintain the listing of Murphy Canyon’s common stock on Nasdaq following the Business Combination; the risk that the
Business Combination disrupts current plans and operations of Conduit as a result of the announcement and consummation of the Business
Combination; the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things,
competition, the ability of the combined company to grow and manage growth economically and hire and retain key employees; the risks
that Conduit’s product candidates in development fail clinical trials or are not approved by the U.S. Food and Drug Administration
or other applicable authorities; costs related to the Business Combination; changes in applicable laws or regulations; the possibility
that Murphy Canyon or Conduit may be adversely affected by other economic, business, and/or competitive factors; and other risks and
uncertainties to be identified in the proxy statement/prospectus relating to the Business Combination, including those under “Risk
Factors” therein, and in other filings with the SEC made by Murphy Canyon. Moreover, Conduit operates in a very competitive and
rapidly changing environment. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified and some of which are beyond Murphy Canyon’s and Conduit’s control, you should not rely on these
forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. Readers
are cautioned not to put undue reliance on forward-looking statements, and except as required by law. Murphy Canyon and Conduit assume
no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future
events, or otherwise. Neither Murphy Canyon nor Conduit gives any assurance that either Murphy Canyon or Conduit or the combined company
will achieve its expectations.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
August 16, 2023 |
MURPHY
CANYON ACQUISITION CORP. |
|
|
|
|
By: |
/s/
Jack K. Heilbron |
|
Name: |
Jack
K. Heilbron |
|
Title: |
Chief
Executive Officer |
Exhibit
99.1
SEC
Declares Form S-4 Registration Statement “Effective” for Proposed Business Combination of Murphy Canyon Acquisition Corp.
with Conduit Pharmaceuticals Limited
| ● | Special
meeting of Murphy Canyon stockholders to vote on the proposed business combination scheduled
for September 7, 2023 |
| ● | Conduit
is a disease agnostic life science company providing an efficient model for compound development
led by a highly experienced team of pharmaceutical executives |
| ● | Murphy
Canyon and Conduit entered into a definitive business combination agreement dated November
8, 2022, as amended (the “Business Combination Agreement”) |
| ● | Combined
company expected to be named Conduit Pharmaceuticals Inc. and listed on Nasdaq in the third
quarter of 2023 under the symbols “CDT” and “CDTTW” |
San
Diego, California (August 16, 2023) — Murphy Canyon Acquisition Corp. (Nasdaq: “MURF” or “Murphy Canyon”),
a blank-check special purpose acquisition company, is pleased to announce that its proxy statement/registration statement on Form S-4
filed with the U.S. Securities and Exchange Commission (“SEC”) on May 12, 2023, as amended (the “Registration Statement”),
was declared effective by the SEC on August 11, 2023. The Registration Statement was filed in connection with the proposed business combination
between Murphy Canyon and Conduit Pharmaceuticals Limited (“Conduit”) previously announced on November 8, 2022.
Conduit
is a disease agnostic life science company providing an efficient model for compound development. Formed in 2019, Conduit is a departure
from the traditional big pharma/biotech business model whereby, typically companies shepherd their assets through regulatory approval,
Conduit acquires assets that are Phase II-ready and then seeks an exit through third-party license deals following successful clinical
trials.
Conduit
is led by a highly experienced team of pharmaceutical executives, including Dr. David Tapolczay and Dr. Freda Lewis-Hall, established
to fund the development of clinical molecules licensed from major pharmaceutical companies. Dr. David Tapolczay will remain Conduit’s
CEO, and Dr. Freda Lewis-Hall will be the Chair of the Board of Directors upon closing of the business combination.
Murphy
Canyon has scheduled a special meeting of its stockholders to seek approval and adoption of the Business Combination Agreement and the
transactions contemplated thereby (the “Transaction”), and other related matters, a key milestone in the business combination
process.
The
Murphy Canyon special meeting of stockholders will be held on September 7, 2023, at 10:00 am Eastern Time. Murphy Canyon’s
common stockholders of record as of the close of business on August 2, 2023, are entitled to receive notice of, to vote, and have their
votes counted at the special meeting and any adjournment thereof.
Murphy
Canyon stockholders can attend, vote and examine the list of Murphy Canyon stockholders entitled to vote at the live webcast of the special
meeting by visiting www.proxyvote.com before the meeting or www.virtualshareholdermeeting.com/MURF2023SM2 during the meeting and
entering the control number found on their proxy card, voting instruction form, or notice they previously received. The special meeting
will be held in a virtual meeting format only. Stockholders will not be able to attend the special meeting physically.
Every
stockholder’s vote FOR ALL Proposals is important, regardless of the number of shares held. If you have any questions or need assistance
voting, please contact D.F. King & Co., Inc., 48 Wall Street, 22nd Floor, New York, NY 10005, Phone: (800) 511-9495, Email: MURF@dfking.com.
Murphy
Canyon’s stockholders were mailed the proxy statement and prospectus in connection with the Transaction beginning August 11, 2023.
The Registration Statement containing the proxy statement and prospectus contains important information about the proposed Transaction,
the Business Combination Agreement, and the proposals to be considered at the special meeting. The Registration Statement containing
the proxy statement, prospectus, and proposals to be considered is available through the SEC’s website.
The
closing of the Transaction, which is expected to occur in the third quarter of 2023, is subject to approval by Murphy Canyon’s
stockholders and the other closing conditions set forth in the definitive Business Combination Agreement. Upon closing, the combined
company will be called “Conduit Pharmaceuticals Inc.”, and its common stock and warrants are expected to be listed on The
Nasdaq Capital Market under the symbols “CDT” and “CDTTW,” respectively.
About
Conduit Pharmaceuticals Limited
Conduit
is a disease agnostic life science company providing an efficient model for compound development. Formed in 2019, Conduit is a departure
from the traditional big pharma/biotech business model whereby, typically companies shepherd their assets through regulatory approval,
Conduit acquires assets that are Phase II-ready and then seeks an exit through third-party license deals following successful clinical
trials. Conduit is led by a highly experienced team of pharmaceutical executives, including Dr. David Tapolczay and Dr. Freda Lewis-Hall,
established to fund the development of clinical molecules licensed from major pharmaceutical companies.
About
Murphy Canyon Acquisition Corp.
Murphy
Canyon is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses. Management is led by Jack Heilbron, Chief Executive Officer and Chairman
of the Board of Directors. Murphy Canyon is sponsored by Murphy Canyon Acquisition Sponsor, LLC, a wholly owned subsidiary of Presidio
Property Trust, Inc. (Nasdaq: SQFT), which would own 4,015,250 shares of Conduit after the successful completion of the business combination.
Important
Information for Investors and Stockholders and Where to Find It
In
connection with the transactions described herein, Murphy Canyon filed its Registration Statement on Form S-4 that includes a proxy statement
with respect to the stockholder meeting of Murphy Canyon and a prospectus with respect to securities of the combined company. The proxy
statement/prospectus was sent to all Murphy Canyon stockholders. Murphy Canyon will also file other documents regarding the proposed
Business Combination with the SEC. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITIES HOLDERS OF MURPHY CANYON ARE URGED TO
READ THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE
PROPOSED BUSINESS COMBINATION AS THEY BECOME AVAILABLE SINCE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION
AND THE PARTIES TO THE PROPOSED BUSINESS COMBINATION.
Investors
and securities holders are able to obtain free copies of the Registration Statement, proxy statement/prospectus and all other relevant
documents filed or that will be filed with the SEC by Murphy Canyon through the website maintained by the SEC at https://sec.gov/. In
addition, the documents filed by Murphy Canyon may be obtained free of charge from Murphy Canyon’s website at https://murphycanyonac.com
or by written request to info@murphycanyonac.com. Additional information about the proposed Transaction, including a copy
of the Business Combination Agreement and investor presentations, were provided in Current Reports on Form 8-K filed by Murphy Canyon
with the SEC which can be accessed at www.sec.gov as well as online at https://murphycanyonac.com.
Participants
in Solicitation
Murphy
Canyon, Conduit, and their respective directors and executive officers, under SEC rules, may be deemed to be participants in the solicitation
of proxies of Murphy Canyon’s stockholders in connection with the proposed business combination. Investors and security holders
may obtain more detailed information regarding the names and interests in the proposed business combination of Murphy Canyon’s
directors and officers in Murphy Canyon’s filings with the SEC, including Murphy Canyon’s initial public offering prospectus,
which was filed with the SEC on February 2, 2022, Murphy Canyon’s subsequent quarterly reports on Form 10-Q, annual reports on
Form 10-K and the Registration Statement. To the extent that holdings of Murphy Canyon’s securities by Murphy Canyon’s insiders
have changed from the amounts reported therein, any such changes have been or will be reflected on Statements of Change in Ownership
on Form 4 filed with the SEC. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation
of proxies to Murphy Canyon’s stockholders in connection with the business combination are included in the proxy statement/prospectus
relating to the proposed business combination. You may obtain free copies of these documents as described in the preceding paragraph.
No
Offer or Solicitation
This
communication shall not constitute a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities
or in respect of the proposed business combination. This communication shall also not constitute an offer to sell or a solicitation of
an offer to buy any securities of Murphy Canyon or Conduit, nor shall there be any sale of securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10
of the Securities Act of 1933, as amended.
Forward-Looking
Statements
This
press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed
transaction between Murphy Canyon and Conduit. All statements other than statements of historical facts contained in this press release,
including statements regarding Murphy Canyon or Conduit’s future results of operations and financial position, the amount of cash
expected to be available to Conduit after the closing and giving effect to any redemptions by Murphy Canyon’s stockholders, Conduit’s
business strategy, prospective product candidates, product approvals, research and development costs, timing and likelihood of success,
plans and objectives of management for future operations, future results of current and anticipated product candidates, and expected
use of proceeds, are forward-looking statements. These forward-looking statements generally are identified by the words “believe,”
“project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,”
“future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,”
“will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, the following risks relating
to the proposed transaction: the occurrence of any event, change or other circumstances that could give rise to the termination of the
Business Combination Agreement; the risk that the transaction may not be completed in a timely manner or at all, which may adversely
affect the price of Murphy Canyon’s securities; the occurrence of any event, change or other circumstances that could give rise
to the termination of the Business Combination Agreement; the inability to complete the Transaction, including due to failure to obtain
approval of the stockholders of Murphy Canyon or other conditions to closing in the Business Combination Agreement; the inability to
obtain or maintain the listing of Murphy Canyon’s common stock on Nasdaq following the Transaction; the risk that the Transaction
disrupts current plans and operations of Conduit as a result of the announcement and consummation of the Transaction; the ability to
recognize the anticipated benefits of the Transaction, which may be affected by, among other things, competition, the ability of the
combined company to grow and manage growth economically and hire and retain key employees; the risks that Conduit’s product candidates
in development fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable authorities; costs
related to the Transaction; changes in applicable laws or regulations; the possibility that Murphy Canyon or Conduit may be adversely
affected by other economic, business, and/or competitive factors; and other risks and uncertainties to be identified in the proxy statement/prospectus
relating to the Transaction, including those under “Risk Factors” therein, and in other filings with the SEC made by Murphy
Canyon. Moreover, Conduit operates in a very competitive and rapidly changing environment. Because forward-looking statements are inherently
subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond Murphy Canyon’s
and Conduit’s control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking
statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and
except as required by law. Murphy Canyon and Conduit assume no obligation and do not intend to update or revise these forward-looking
statements, whether as a result of new information, future events, or otherwise. Neither Murphy Canyon nor Conduit gives any assurance
that either Murphy Canyon or Conduit or the combined company will achieve its expectations.
Contacts
Adam
Sragovicz
Murphy
Canyon Acquisition Corp.:
adam.sragovicz@murphycanyonac.com
Jamie
Bligh
Conduit
Pharmaceuticals Limited
jb@conduitpharma.com
v3.23.2
Cover
|
Aug. 16, 2023 |
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Aug. 16, 2023
|
Entity File Number |
001-41245
|
Entity Registrant Name |
Murphy
Canyon Acquisition Corp.
|
Entity Central Index Key |
0001896212
|
Entity Tax Identification Number |
87-3272543
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
4995
Murphy Canyon Road
|
Entity Address, Address Line Two |
Suite 300
|
Entity Address, City or Town |
San
Diego
|
Entity Address, State or Province |
CA
|
Entity Address, Postal Zip Code |
92123
|
City Area Code |
760
|
Local Phone Number |
471-8536
|
Written Communications |
true
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant |
|
Title of 12(b) Security |
Units,
each consisting of one share of Class A Common Stock and one Redeemable Warrant
|
Trading Symbol |
MURFU
|
Security Exchange Name |
NASDAQ
|
Class A Common Stock, par value $0.0001 per share |
|
Title of 12(b) Security |
Class
A Common Stock, par value $0.0001 per share
|
Trading Symbol |
MURF
|
Security Exchange Name |
NASDAQ
|
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 |
|
Title of 12(b) Security |
Redeemable
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
|
Trading Symbol |
MURFW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=MURF_UnitsEachConsistingOfOneShareOfClassCommonStockAndOneRedeemableWarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=MURF_ClassCommonStockParValue0.0001PerShareMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=MURF_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Murphy Canyon Acquisition (NASDAQ:MURFU)
Historical Stock Chart
From Apr 2024 to May 2024
Murphy Canyon Acquisition (NASDAQ:MURFU)
Historical Stock Chart
From May 2023 to May 2024